查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1497544

生物標記測試服務市場：按服務、技術、疾病領域、應用、最終用戶 - 2024-2030 年全球預測

Biomarker Testing Services Market by Services, Techonology, Disease Area, Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

生物標記檢測服務市場規模預計2023年為9.649億美元，2024年達到10.3196億美元，預計2030年將達到15.8504億美元，複合年成長率為7.34%。

生物標記檢測服務是對人體內生物標記的臨床評估和分析，這些生物標記表明正常或病理症狀以及對治療性介入的藥理反應。生物標記在癌症、心血管疾病、神經系統疾病等多種疾病的早期檢測、診斷和治療效果監測中發揮重要作用。全球遺傳和慢性疾病數量的增加、人們對生物標記在個人化醫療中的效用的日益認知以及生物技術的進步推動了對生物標記測試服務的需求。生物標記特異性測試和治療方法的核准也得到支持性監管環境的支持。然而，與生物標記測試相關的高成本以及對先進基礎設施和技術的需求是主要障礙。此外，缺乏普遍接受的生物標記測試和檢驗過程標準使生物標記測試在臨床實踐中的普及變得複雜，並且生物標記測試的技術限制引起了人們對該技術準確性的擔憂。然而，為了提高生物標記測試的準確性和可靠性，主要企業正在探索生物資訊學、基因組學和蛋白​​質組學的進步。此外，整合 AL/ML 和資料分析技術以增強生物標記分析和解釋，以及學術機構、醫療保健提供者和產業參與企業之間的合作以加速生物標記研究和應用，將進一步推動產業成長。

主要市場統計
基準年[2023] 9.649 億美元
預測年份 [2024] 1,031,960,000 美元
預測年份 [2030] 15.8504億美元
複合年成長率（%） 7.34%

區域洞察

以美國和加拿大為中心的美洲地區由於其先進的醫療基礎設施、高昂的醫療成本以及對研究和創新的高度重視，成為生物標記檢測服務的重要市場。由於個人化醫療的趨勢以及旨在早期發現和管理疾病的政府積極努力，美國在生物標記檢測的採用方面處於領先地位。該地區還支持多項與生物標記技術相關的專利，顯示該地區致力於開發更準確和更具預測性的診斷工具。由於其高度發展的醫療部門以及由 Horizo​​​​n Europe 等歐盟衛生計畫支持的廣泛研究活動，歐盟國家正在經歷越來越多的生物標記物的採用。最近的焦點是腫瘤學和神經系統疾病，其中許多舉措旨在將生物標記測試納入臨床實踐，以實現個人化治療方法。歐盟對生物標記開發和生物標記測試的嚴格規定創建了支持生物技術創新的標準化框架。由於對衛生基礎設施的大量投資以及對預防性醫療保健日益成長的興趣，中東是一個充滿希望的地區。在亞太地區，中國、日本和印度等國家正在展示生物標記測試服務的創新。這些國家的需求是由不斷成長的醫療保健支出、日益增強的個人化醫療意識以及蓬勃發展的生物製藥行業所推動的。由於政府和私營部門對研發的投資，中國的分子診斷技術正在快速發展。日本以其技術創新而聞名，在老齡化社會中，旨在早期檢測和治療策略的先進生物標記測試的採用率很高。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在生物標記測試服務市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對生物標記物測試服務市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該細分市場競爭力的寶貴見解，包括研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在生物標記測試服務市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行概述

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症治療的發展和對高性能生物標記的需求增加
      • 政府對生物標誌研究的措施和投資
      • 改善生物標記測試的財務支援的可用性
    • 抑制因素
      • 生物標記測試是一個緩慢且昂貴的過程
    • 機會
      • 使用人工智慧和機器學習的生物標記測試工具和設備的進步
      • 提供生物標記測試和分析服務的新興CDMO
    • 任務
      • 由於樣本收集和缺乏可靠性而造成測試障礙
  • 市場區隔分析
    • 技術：不斷進步，提升聚合酵素鏈鎖反應技術的通用性、速度和擴增能力
    • 最終用戶：生物標記測試服務在製藥和生物技術公司治療性介入的新用途
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章生物標記測試服務市場：依服務分類

  • 介紹
  • 生物標記測定的開發和檢驗
  • 流式細胞技術

第7章生物標記測試服務市場：依技術分類

  • 介紹
  • 酵素免疫分析法
  • 質譜
  • 次世代定序
  • 聚合酵素鏈鎖反應

第8章生物標記檢測服務市場：依疾病領域

  • 介紹
  • 自體免疫疾病
  • 癌症
  • 心血管疾病
  • 神經系統疾病

第9章生物標記測試服務市場：依應用分類

  • 介紹
  • 藥物作用機制
  • 動態
  • 預測性臨床研究
  • 預後

第 10 章 生物標記測試服務市場：依最終用戶分類

  • 介紹
  • 合約研究組織
  • 製藥和生物技術公司
  • 研究機構

第11章美洲生物標記檢測服務市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太生物標記檢測服務市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲/中東/非洲生物標記檢測服務市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Mayo Clinic Laboratories 和 Progentec 合作為自體免疫疾病患者提供先進的生物標記檢測服務
    • 新的前列腺癌生物標記測試登陸美國市場
    • Quanterix 推出 LucentAD 生物標記血液檢測，幫助醫生診斷阿茲海默症患者
  • 戰略分析和建議

第15章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-B16853779DF0

[180 Pages Report] The Biomarker Testing Services Market size was estimated at USD 964.90 million in 2023 and expected to reach USD 1,031.96 million in 2024, at a CAGR 7.34% to reach USD 1,585.04 million by 2030.

Biomarker testing services refer to the clinical evaluation and analysis of biological markers (biomarkers) in the human body, which are indicative of normal or pathological symptoms or pharmacologic responses to a therapeutic treatment intervention. Biomarkers play a critical role in early detection, diagnosis, and monitoring the efficacy of treatments for various diseases, including cancer, cardiovascular disorders, and neurological conditions. The need for biomarker testing services is driven by the increasing incidences of genetic and chronic diseases worldwide, the growing recognition of the utility of biomarkers in personalized medicine, and advancements in biotechnology. A supportive regulatory environment has also facilitated the approval of biomarker-based tests and therapies. However, the high costs associated with biomarker tests and the requirement for sophisticated infrastructure and technology pose significant barriers. Additionally, the lack of universally accepted standards for biomarker testing and validation processes complicates their widespread adoption in clinical settings, and technical limitations of biomarker testing raise concerns about the accuracy of the technology. However, key players are exploring advances in bioinformatics, genomics, and proteomics to enhance the accuracy and reliability of biomarker tests. Additionally, the integration of AL/ML and data analytics technologies to enhance biomarker analysis and interpretation and collaborations between academic institutions, healthcare providers, and industry players to accelerate biomarker research and application can further expand the growth of the industry.

KEY MARKET STATISTICS
Base Year [2023] USD 964.90 million
Estimated Year [2024] USD 1,031.96 million
Forecast Year [2030] USD 1,585.04 million
CAGR (%) 7.34%

Regional Insights

The Americas, particularly the U.S. and Canada, represent a significant market for biomarker testing services, attributed to advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on research and innovation. The U.S. leads in the adoption of biomarker tests, driven by personalized healthcare trends and proactive government initiatives aiming at early disease detection and management. The region also supports numerous patents related to biomarker technology, showcasing a strong emphasis on developing more precise and predictive diagnostic tools. EU countries are witnessing a growing adoption of biomarker testing services due to the highly developed healthcare sector and extensive research activities supported by the EU's health programs, such as Horizon Europe. The recent focus has been on oncology and neurological disorders, with numerous initiatives aimed at integrating biomarker testing into clinical practice to enable personalized treatment approaches. EU's stringent regulations pertaining to biomarker development and biomarker testing have created a standardized framework for supporting innovations in biotechnology. The Middle East shows promise due to substantial investments in healthcare infrastructure and an increasing focus on preventative care. In the APAC region, nations such as China, Japan, and India showcase innovation in biomarker testing services. The need in these countries is driven by increasing healthcare spending, rising awareness regarding personalized medicine, and the burgeoning biopharmaceutical sector. China is witnessing rapid advancements in molecular diagnostics, fueled by both government and private sector investments in research and development. Japan, renowned for its technological innovation, sees a high adoption rate of advanced biomarker tests among its aging population, aiming for early detection and treatment strategies.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Biomarker Testing Services Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing cancer drug development and need for high-performing biomarkers
      • Government initiatives and investments for biomarker research
      • Improved availability of financial coverage for biomarker testing
    • Market Restraints
      • Time-consuming and expensive process of biomarker testing
    • Market Opportunities
      • Advancements in biomarker testing tools & equipment with AI & ML
      • Emerging CDMOs offering biomarker testing and analysis services
    • Market Challenges
      • Barriers in testing due to lack of sample collection and authenticity
  • Market Segmentation Analysis
    • Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
    • End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biomarker Testing Services Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biomarker Testing Services Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases

In a strategic move poised to transform autoimmune disease management, Mayo Clinic Laboratories, has teamed up with Progentec Diagnostics, an innovator in digital health and biomarker technologies. This collaboration is set to deliver Progentec's novel suite of biomarker blood tests across the U.S. and selected international markets, enhancing the accessibility of advanced diagnostic solutions for both healthcare providers and patients battling autoimmune diseases. [Published On: 2023-11-14]

Novel Prostate Cancer Biomarker Test Launches on US Market

Quest Diagnostics, in collaboration with Envision Sciences, has launched an innovative prostate cancer biomarker test in the United States, a groundbreaking development aimed at enhancing the precision of prostate cancer biopsy grading. This strategic collaboration seeks to address a significant clinical need impacting millions of men in their cancer staging, diagnosis, and treatment journeys. [Published On: 2023-08-10]

Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer's Disease In Patients

Quanterix Corporation has launched its innovative LucentAD test, designed to facilitate the evaluation process for healthcare providers in diagnosing early signs of Alzheimer's disease (AD) in patients presenting cognitive symptoms. This cutting-edge test aims to streamline the process for clinicians when assessing the likelihood of amyloid pathology-an indicator of Alzheimer's disease. [Published On: 2023-07-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biomarker Testing Services Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biomarker Testing Services Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Agilent Technologies, Inc., Avid Bioservices, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, BiomarkerBay B. V., Bristol Myers Squibb, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Icon PLC, Intertek Group PLC, IQVIA, JSR Life Sciences, LLC, KCAS Group, Laboratory Corporation of America Holdings, LGC Group, Merck KGaA, Myriad Genetics, Inc., NeoGenomics Laboratories, Parexel International Corporation, PerkinElmer Inc., Randox Laboratories, SGS S.A., Shuwen Biotech Co., Ltd., Syneos Health, Thermo Fisher Scientific, Inc., and WuXi Biologics Inc..

Market Segmentation & Coverage

This research report categorizes the Biomarker Testing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Biomarker Assay Development & Validation
    • Flow Cytometry
  • Techonology
    • Enzyme-Linked Immunosorbent Assay
    • Mass Spectrometry
    • Next-Generation Sequencing
    • Polymerase Chain Reaction
  • Disease Area
    • Autoimmune Diseases
    • Cancer
    • Cardiovascular Diseases
    • Neurological Disorders
  • Application
    • Drug Mechanism of Action
    • Pharmacodynamic
    • Predictive Clinical Studies
    • Prognostic
  • End-User
    • Contract Research Oraganizations
    • Pharmaceutical & biotechnology companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cancer drug development and need for high-performing biomarkers
      • 5.1.1.2. Government initiatives and investments for biomarker research
      • 5.1.1.3. Improved availability of financial coverage for biomarker testing
    • 5.1.2. Restraints
      • 5.1.2.1. Time-consuming and expensive process of biomarker testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in biomarker testing tools & equipment with AI & ML
      • 5.1.3.2. Emerging CDMOs offering biomarker testing and analysis services
    • 5.1.4. Challenges
      • 5.1.4.1. Barriers in testing due to lack of sample collection and authenticity
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Ongoing advancements to improve the versatility, speed, and amplification capabilities of polymerase chain reaction technology
    • 5.2.2. End-User: Emerging utilization of biomarker testing services by pharmaceutical & biotechnology companies for therapeutic interventions
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Biomarker Testing Services Market, by Services

  • 6.1. Introduction
  • 6.2. Biomarker Assay Development & Validation
  • 6.3. Flow Cytometry

7. Biomarker Testing Services Market, by Techonology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Mass Spectrometry
  • 7.4. Next-Generation Sequencing
  • 7.5. Polymerase Chain Reaction

8. Biomarker Testing Services Market, by Disease Area

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cancer
  • 8.4. Cardiovascular Diseases
  • 8.5. Neurological Disorders

9. Biomarker Testing Services Market, by Application

  • 9.1. Introduction
  • 9.2. Drug Mechanism of Action
  • 9.3. Pharmacodynamic
  • 9.4. Predictive Clinical Studies
  • 9.5. Prognostic

10. Biomarker Testing Services Market, by End-User

  • 10.1. Introduction
  • 10.2. Contract Research Oraganizations
  • 10.3. Pharmaceutical & biotechnology companies
  • 10.4. Research Institutes

11. Americas Biomarker Testing Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Biomarker Testing Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Biomarker Testing Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Mayo Clinic Laboratories and Progentec Collaborate To Bring Advanced Biomarker Testing Services To Patients With Autoimmune Diseases
    • 14.3.2. Novel Prostate Cancer Biomarker Test Launches on US Market
    • 14.3.3. Quanterix Launches LucentAD Biomarker Blood Test To Aid Physician Diagnosis of Alzheimer's Disease In Patients
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BIOMARKER TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMARKER TESTING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOMARKER TESTING SERVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. BIOMARKER TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. BIOMARKER TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOMARKER TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY BIOMARKER ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY DRUG MECHANISM OF ACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACODYNAMIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PREDICTIVE CLINICAL STUDIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PROGNOSTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORAGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES BIOMARKER TESTING SERVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL BIOMARKER TESTING SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY TECHONOLOGY, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY DISEASE AREA, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY BIOMARKER TESTING SERVICES MARKET SIZE, BY A